A Brain Implant for Depression Is About to Be Tested in Humans

The latest brain-computer interface could assistance radical retrieve from terrible depression. Motif Neurotech announced Monday that the US Food and Drug Administration has approved a quality survey to proceedings the company's blueberry-sized encephalon implant that sits successful the skull and delivers electrical stimulation to dainty depression.

The Houston-based startup, founded successful 2022, is portion of a budding manufacture pursuing exertion to work and construe encephalon signals. While different companies exploring akin technology, similar Elon Musk’s Neuralink, Paradromics, and Synchron, are processing devices to alteration paralyzed radical to pass and usage computers, Motif is aiming to easiness slump successful radical who person not benefited from medication.

The company’s instrumentality is implanted successful the skull conscionable supra the dura, the brain’s protective membrane. It targets the cardinal enforcement network, a portion of the encephalon that is liable for high-level cognitive functions and is underactive successful large depressive disorder. The implant emits circumstantial patterns of stimulation to crook “on” this network.

Motif’s instrumentality would let patients to person therapeutic encephalon stimulation astatine home. “Through predominant electrical stimulation, we deliberation we tin thrust that neuroplasticity that creates stronger connectivity wrong the cardinal enforcement web for patients with depression, truthful that they tin get retired of furniture successful the morning, telephone their friends, spell to the gym,” says Jacob Robinson, Motif’s cofounder and CEO.

Electrical stimulation has been utilized for decades to dainty depression, and Motif’s attack is conscionable the latest iteration. Electroconvulsive oregon “shock” therapy began successful the 1930s and is inactive utilized contiguous successful cases wherever patients don’t payment from antidepressants. Deep encephalon stimulation, which involves surgically implanting electrodes into the brain, is occasionally utilized experimentally but is not FDA approved. A overmuch milder signifier of stimulation known arsenic transcranial magnetic stimulation, oregon TMS, was approved successful 2008. While it tin beryllium highly effective, it typically requires a lengthy attraction regimen of 5 treatments a week for six weeks.

A survey from 2021 recovered that during a 12-month play successful the United States, astir 9 cardinal adults were undergoing attraction for large depressive disorder, and of those, astir 3 cardinal were considered to person treatment-resistant depression, erstwhile symptoms bash not amended aft astatine slightest two, and often more, antidepressant medications.

Motif’s instrumentality tin beryllium implanted successful a 20-minute outpatient process without the request for encephalon surgery. It’s powered by wireless magnetoelectric exertion that Robinson developed portion astatine Rice University and is charged with a shot headdress that patients volition deterioration erstwhile receiving the stimulation.